Applied Clinical Trials

Applied Clinical Trials-06-01-2025
Volume: 34
Issue: 3

Applied Clinical Trials-04-01-2025
Volume: 34
Issue: 2

Applied Clinical Trials-02-01-2025
Volume: 34
Issue: 1

Applied Clinical Trials-12-01-2024
Volume: 33
Issue: 12

Applied Clinical Trials-11-01-2024
Volume: 33
Issue: 11

Applied Clinical Trials-10-01-2024
Volume: 33
Issue: 10

Applied Clinical Trials-09-01-2024
Volume: 33
Issue: 9

Applied Clinical Trials-08-01-2024
Volume: 33
Issue: 8

Applied Clinical Trials-06-01-2024
Volume: 33
Issue: 6

Applied Clinical Trials-05-01-2024
Volume: 33
Issue: 5

Applied Clinical Trials-04-01-2024
Volume: 33
Issue: 4

Applied Clinical Trials-03-01-2024
Volume: 33
Issue: 3

Applied Clinical Trials-02-01-2024
Volume: 33
Issue: 1/2

Applied Clinical Trials-12-01-2023
Volume: 32
Issue: 12

Applied Clinical Trials-11-01-2023
Volume: 32
Issue: 11

Applied Clinical Trials-10-01-2023
Volume: 32
Issue: 10

Applied Clinical Trials-09-01-2023
Volume: 32
Issue: 9

Applied Clinical Trials-08-01-2023
Volume: 32
Issue: 7/8

Applied Clinical Trials-06-01-2023
Volume: 32
Issue: 6

Applied Clinical Trials-05-01-2023
Volume: 32
Issue: 5

Applied Clinical Trials-04-01-2023
Volume: 32
Issue: 4

Applied Clinical Trials-03-01-2023
Volume: 32
Issue: 3

Applied Clinical Trials-02-01-2023
Volume: 32
Issue: 1/2

Applied Clinical Trials-12-01-2022
Volume: 31
Issue: 12

Applied Clinical Trials-11-01-2022
Volume: 31
Issue: 11

Applied Clinical Trials-10-01-2022
Volume: 31
Issue: 10

Applied Clinical Trials-09-01-2022
Volume: 31
Issue: 9

Applied Clinical Trials-08-01-2022
Volume: 31
Issue: 7/8

Applied Clinical Trials-06-01-2022
Volume: 31
Issue: 6

Applied Clinical Trials-05-01-2022
Volume: 31
Issue: 5
Advertisement
Advertisement
Trending on Applied Clinical Trials Online
1
Merck Reports Strong Phase II Results for Ifinatamab Deruxtecan in Extensive-Stage Small Cell Lung Cancer
2
Phase IV Trial Shows Daybue Demonstrates Real-World Behavioral Improvements in Rett Syndrome
3
ACT Brief Weekly Recap: How AI, eClinical Innovation, and Policy Shifts Are Reshaping Clinical Research
4
Capvaxive Demonstrates Robust Immune Responses in Children, Adolescents at Increased Risk of Pneumococcal Disease
5